Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
Merrill D. Benson(Indiana University School of Medicine), Teresa Coelho(Universidade do Porto), Stephen B. Heitner(Brigham and Women's Hospital), Morie A. Gertz(Medical University of South Carolina), Giuseppe Vita(University of Messina), Peter D. Gorevic(Université Paris-Sud), John L. Berk(Boston University), Hartmut Schmidt(Université Paris-Sud), Jesse Kwoh(Ionis Pharmaceuticals (United States)), Márcia Waddington‐Cruz(Université Paris-Sud), William J. Litchy(Mayo Clinic), Annabel K. Wang(Université Paris-Sud), Amil M. Shah(Brigham and Women's Hospital), Brenda F. Baker(Ionis Pharmaceuticals (United States)), Josep M. Campistol(Universitat de Barcelona), Violaine Planté‐Bordeneuve(Université Paris-Est Créteil), Brett P. Monia(Ionis Pharmaceuticals (United States)), Fábio Barroso(Université Paris-Sud), Scott D. Solomon(Brigham and Women's Hospital), Carol Whelan(The Royal Free Hospital), Thomas H. Brannagan(Columbia University), Isabel Conceição(Université Paris-Sud), Brian Drachman(Penn Presbyterian Medical Center), Laura Obici(University of Pavia), Steven G. Hughes(Ionis Pharmaceuticals (United States)), Michael Polydefkis(Université Paris-Sud), Josep Gámez(Université Paris-Sud), Giampaolo Merlini(University of Pavia), Morton Scheinberg(Université Paris-Sud), Edward Gane(University of Auckland), David Adams(Mount Sinai Health System), Elizabeth J. Ackermann(Université Paris-Sud), P. James B. Dyck(Mayo Clinic), Shiangtung W. Jung(Université Paris-Sud), Bradley McEvoy(Université Paris-Sud)
Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
July 1, 2018
Cited by 0
Related Papers
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
|Journal of the American Society of Echocardiography|2005|11.3k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2018|2.8k